Association of immunoexpression of the galectins-3 and -7 with histopathological and clinical parameters in oral squamous cell carcinoma in young patients

European Archives of Oto-Rhino-Laryngology

Volumn 273, Issue 1, 2016, Pages 237-243

  Mesquita, Janaina Almeida ^a   Queiroz, Lélia Maria Guedes ^b   Silveira, Éricka Janine Dantas ^b   Gordon Nunez, Manuel Antônio ^a   Godoy, Gustavo Pina ^a   Nonaka, Cassiano Franscisco Weege ^a   Alves, Pollianna Muniz ^a  

^a STATE UNIVERSITY OF PARAÍBA   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

Author keywords

Galectins; Immunohistochemistry; Oral squamous cell carcinoma; Young adult

Indexed keywords

ANTIBODY; GALECTIN 3; GALECTIN 7; GALECTIN; GALECTIN-3, HUMAN; LGALS7 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; ARTICLE; BRAZIL; CANCER GRADING; CANCER PATIENT; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GROUPS BY AGE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MORPHOLOGY; MOUTH SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; WORLD HEALTH ORGANIZATION; IMMUNOLOGY; METABOLISM; MOUTH TUMOR; PATHOLOGY; PATHOPHYSIOLOGY; PROGNOSIS; SQUAMOUS CELL CARCINOMA; STATISTICS;

ADULT; BIOMARKERS, TUMOR; BRAZIL; CARCINOMA, SQUAMOUS CELL; FEMALE; GALECTIN 3; GALECTINS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MOUTH NEOPLASMS; NEOPLASM GRADING; NEOPLASM STAGING; PROGNOSIS; STATISTICS AS TOPIC;

EID: 84953358766     PISSN: 09374477     EISSN: 14344726     Source Type: Journal    
DOI: 10.1007/s00405-014-3439-y     Document Type: Article

References (31)

1. Ribeiro ACP, Silva ARS, Simonato LE, Salzedas LMP, Sundefeld MLMM, Soubhia AMP (2009) Clinical and histopathological analysis of oral squamous cell carcinoma in young people: a descriptive study in Brazilians. Br J Oral Maxillofac Surg 47:95–98. doi:10.1016/j.bjoms.2008.05.004
2. Benevenuto TG, Nonaka CFW, Pinto LP, Souza LB (2012) Immunohistochemical comparative analysis of cell proliferation and angiogenic index in squamous cell carcinomas of the tongue between young and older patients. Appl Immunohistochem Mol Morphol 20:291–297. doi:10.1097/PAI.0b013e31823277f6
3. Soudry E, Preis M, Hod R, Hamzany Y, Hadar T, Bahar G, Strenov Y, Shpitzer T (2010) Squamous cell carcinoma of the oral tongue in patients younger than 30 years: clinicopathologic features and outcome. Clin Otolaryngol 35:307–312. doi:10.1111/j.1749-4486.2010.02164.x
4. Van Monsjou HS, Van Velthuysen MLF, Van Den Brekel MWM, Jordanova ES, Melief CJM, Balm AJM (2012) Human papillomavirus status in young patients with head and neck squamous cell carcinoma. Int J Cancer 130:1806–1812. doi:10.1002/ijc.26195
5. Patel SC, Carpenter WR, Tyree S, Couch ME, Weisller M, Hackman T, Hayes DN, Shores C, Chera BS (2011) Increasing incidence of oral tongue squamous cell carcinoma in young white women, age 18 to 44 years. J Clin Oncol 29:1488–1494. doi:10.1200/jco.2010.31.7883
6. Kaminagakura E, Vartanian GJ, Silva SDS, Santos CR, Kowalski LP (2010) Case-control study on prognostic factors in oral squamous cell carcinoma in young patients. Head Neck 32:1460–1466. doi:10.1002/hed.21618
7. Beena VT, Chauhan I, Heera R, Rajeev R (2011) Oral cancer in young non-habituè females: a report of four cases and review of the literature. Aust Dent J 56:322–327. doi:10.1111/j.1834-7819.2011.01344.x
8. Falaki F, Dalirsani Z, Pakfetrat A, Falaki A, Saghravanian N, Nosratzehi T, Pazouki M (2011) Clinical and histopathological analysis of oral Squamous cell carcinoma of young patients in Mashhad, Iran: A retrospective study and review of literatures. Med Oral Patol Oral Cir Bucal 16:473–477. doi:10.4317/medoral.16.e473
9. Alves PM, Godoy GP, Gomes DQ, Medeiros AMC, Souza LB, Silveira EJD, Vasconcelos MG, Queiroz LMG (2011) Significance of galectins-1, -3, -4 and -7 in the progression of squamous cell carcinoma of the tongue. Pathol Res Pract 207:236–240. doi:10.1016/j.prp.2011.02.004
10. Carvalho MV, Pereira JS, Alves PM, Silveira EJD, Souza LB, Queiroz LMG (2013) Alterations in the immunoexpression of galectins-1, -3 and -7 between different grades of oral epithelial dysplasia. J Oral Pathol Med 42:174–179. doi:10.1111/j.1600-0714.2012.01199.x
11. Faria PR, Chammas R, Melo TL, Hsu DK, Liu FT, Nonogaki S, Cardoso SV, Loyola AM (2011) Absence of galectin-3 does not affect the development of experimental tongue carcinomas in mice. Exp Mol Pathol 90:189–193. doi:10.1016/j.yexmp.2010.12.007
12. Kosacka M, Piesiak P, Kowal A, Gołecki M, Jankowska R (2011) Galectin-3 and cyclin D1 expression in non-small cell lung câncer. J Exp Clin Cancer Res 30:2–7. doi:10.1186/1756-9966-30-101
13. Saussez S, Lorfevre F, Lequeux T, Laurent G, Chantrain G, Vertongen F, Toubeau G, Decastercker C, Kiss R (2008) The determination of the levels of circulating galectin-1 and -3 in HNSCC patients could be used to monitor tumor progression and/or responses to the therapy. Oral Oncol 44:86–93. doi:10.1016/j.oraloncology.2006.12.014
14. Bryne MS, Koppang HS, Lilleng R, Kjaerheim A (1992) Malignancy grading of the deep invasive margins of oral squamous cell carcinomas has high prognostic value. J Pathol 166:375–381
15. Barnes L, Eveson JW, Reichart P, Sidransky D (2005) Pathology and genetics of head and neck tumours: Word Health Organization classification of tumours. IARC Press, Lyon (France), pp 122–125
16. Chiang WF, Liu SY, Fang LY, Lin CN, Wu MH, Chen YC, Chen YL, Jin YT (2008) Overexpression of galectin-1 at the tumor invasion front is associated with poor prognosis in early stage oral squamous cell carcinoma. Oral Oncol 44:325–334. doi:10.1016/j.oraloncology.2007.03.004
17. Honjo Y, Inohara H, Akahani S, Yoshii T, Takenaka Y, Yoshida J, Hattori K, Tomiyama Y, Raz A, Kubo T (2000) Expression of cytoplasmic galectin-3 as a prognostic marker in tongue carcinoma. Clin Cancer Res 6:4635–4640
18. Than TH, Swethadri GK, Wong J, Ahmad T, Jamil D, Maganlal RK (2008) Expression of galectin-3 and galectin-7 in thyroid malignancy as potential diagnostic indicators. Singapore Med J 49:333–338
19. Mallet Y, Avalos N, Ridant AL, Gangloff P, Moriniere S, Rame JP, Poissonnet G, Makeieff M, Cosmidis A, Babin E, Barry B, Fournier C (2009) Head and neck cancer in young people: a series of 52 SCCs of the oral tongue in patients aged 35 years or less. Acta Otolaryngol 129:1503–1508. doi:10.3109/00016480902798343
20. Alsharif MJ, Jiang WA, He S, Zhao Y, Shan Z, Chen X (2009) Gingival squamous cell carcinoma in young patients: report of a case and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 107:696–700. doi:10.1016/j.tripleo.2008.12.048
21. Santos-Silva AR, Ribeiro ACP, Soubhia AMP, Miyahara GI, Carlos R, Speight PM, Hunter KD, Torres-Rendon A, Vargas PA, Lopes MA (2011) High incidences of DNA ploidy abnormalities in tongue squamous cell carcinoma of young patients: an international collaborative study. Histopathology 58:1127–1135. doi:10.1111/j.1365-2559.2011.03863.x
22. INK4A genetic and epigenetic profiles differ in relation to age and site in head and neck squamous cell carcinomas. Hum Pathol 39:452–458. doi:10.1016/j.humpath.2007.08.004
23. Vered M, Dayan D, Dobriyan A, Yahalom R, Shalmon B, Barshack I, Bedrin L, Talmi YP, Taicher S (2010) Oral tongue squamous cell carcinoma: recurrent disease is associated with histopathologic risk score and young age. J Cancer Res Clin Oncol 136:1039–1048. doi:10.1007/s00432-009-0749-3
24. Dumic J, Dabelic S, Flögel M (2006) Galectin-3: an open-ended story. Biochim Biophys Acta 1760:616–635. doi:10.1016/j.bbagen.2005.12.020
25. Kapucuoglu N, Basakb PY, Bircana S, Serta S, Akkayab VB (2009) Immunohistochemical galectin-3 expression in non-melanoma skin cancers. Pathol Res Pract 205:97–103. doi:10.1016/j.prp.2008.09.001
26. Delorge S, Saussez S, Pelc P, Devroede B, Marchant H, Burchert M, Danguy A, Salmon I, Gabius HJ, Kiss R, Hassid S (2000) Correlation of galectin-3/galectin-3-binding sites with low differentiation status in head and neck squamous cell carcinomas. Otolaryngol Head Neck Surg 122:834–841. doi:10.1016/S0194-5998(00)70010-6
27. Wang LP, Chen SW, Zhuang SM, Li H, Song M (2013) Galectin-3 accelerates the progression of oral tongue squamous cell carcinoma via a Wnt/β-catenin-dependent pathway. Pathol Oncol Res 19:461–474. doi:10.1007/s12253-013-9603-7
28. Zhu XI, Ding M, Yu M, Feng M, Tan L, Zhao F (2010) Identification of galectin-7 as a potential biomarker for esophageal squamous cell carcinoma by proteomic analysis. BMC Cancer 10:2–12. doi:10.1186/1471-2407-10-290
29. Demers M, Magnaldo T, St-Pierre Y (2005) Novel function for galectin-7: promoting tumorigenesis by up regulating MMP-9 gene expression. Cancer Res 65:5205–5210. doi:10.1158/0008-5472.CAN-05-0134
30. Matsukawa S, Morita KI, Negishi A, Harada H, Nakajima Y, Shimamoto H, Hirofumi T, Tanaka K, Oho M, Yamada T, Omura K (2014) Galectin-7 as a potential predictive marker of radio-therapy resistance in oral squamous cell carcinoma. Cancer Med 3:349–361. doi:10.1002/cam4.195
31. Kuwabara I, Kuwabara Y, Yang RY, Schuler M, Green DR, Zuraw BL, hsu DK, Liu FT (2002) Galectin-7 (PIG1) exhibits pro-apoptotic function through JNK activation and mitochondrial cytochrome C release. JBC 277:3487–3497. doi:10.1074/jbc.M109360200